Answers are grounded in this paper and cite their sources.
Demonstrates increased expectant management intent following low sFlt-1/PlGF ratio results in hypertensive pregnancy, indicating potential to avoid unnecessary deliveries.
Hypertensive disorders of pregnancy affect 13-16% of U.S. pregnancies and remain a leading cause of maternal and neonatal morbidity. Management is complicated by diagnostic uncertainty, as most markers rise only after end-organ injury. The sFlt-1/PlGF ratio has shown strong prognostic value, but its effect, on U.S. clinical management decisions, is unknown. We conducted a case-based webinar with obstetric and maternal-fetal medicine providers (n = 68) to assess changes in management intent after a low ratio result. Expectant management intent rose from 20.9% to 87.8%, while delivery intent decreased. These findings suggest sFlt-1/PlGF biomarker data may influence intended patient management.
No takes yet. Share an insight, caveat, or question.
Woodham et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: